Strength training alters MCT1-protein expression and exercise-induced translocation in erythrocytes of men with non-insulin-dependent type-2 diabetes

2014 ◽  
Vol 92 (3) ◽  
pp. 259-262 ◽  
Author(s):  
David Opitz ◽  
Thorsten Kreutz ◽  
Edward Lenzen ◽  
Benedict Dillkofer ◽  
Patrick Wahl ◽  
...  

We investigated the cellular distribution of lactate transporter (MCT1) and its chaperone CD147 (using immunohistochemistry and fluorescence-activated cell sorting) in the erythrocytes of men with non-insulin-dependent type-2 diabetes (NIDDM, n = 11, 61 ± 8 years of age) under acute exercise (ergometer cycling test, World Health Organisation scheme) performed before and after a 3-month strength training program. Cytosolic MCT1 distribution and membraneous CD147 density did not change after acute exercise (ergometer). After the 3-month strength training, MCT1-density was increased and the reaction of MCT1 (but not that of CD147) towards acute exercise (ergometer) was altered. MCT1 localisation was shifted from the centre to the cellular membrane. This resulted in a decrease in the immunohistochemically measured cytosolic MCT1-density. We conclude that strength training alters the acute exercise reaction of MCT1 but not that of CD147 in erythrocytes in patients with NIDDM. This reaction may contribute to long-term normalisation and stabilisation of the regulation of lactate plasma concentration in NIDDM.

Diabetes Care ◽  
2007 ◽  
Vol 30 (9) ◽  
pp. 2236-2237 ◽  
Author(s):  
S. M. Blevins ◽  
M. J. Leyva ◽  
J. Brown ◽  
J. Wright ◽  
R. H. Scofield ◽  
...  

2011 ◽  
Vol 112 (6) ◽  
pp. 2277-2287 ◽  
Author(s):  
Christian Brinkmann ◽  
Jenny Blossfeld ◽  
Martin Pesch ◽  
Bastian Krone ◽  
Kathrin Wiesiollek ◽  
...  

2018 ◽  
pp. bcr-2017-221854 ◽  
Author(s):  
Suleiman Furmli ◽  
Rami Elmasry ◽  
Megan Ramos ◽  
Jason Fung

This case series documents three patients referred to the Intensive Dietary Management clinic in Toronto, Canada, for insulin-dependent type 2 diabetes. It demonstrates the effectiveness of therapeutic fasting to reverse their insulin resistance, resulting in cessation of insulin therapy while maintaining control of their blood sugars. In addition, these patients were also able to lose significant amounts of body weight, reduce their waist circumference and also reduce their glycated haemoglobin level.


Sign in / Sign up

Export Citation Format

Share Document